The aim was to investigate the prognostic impact of coffee consumption and possible associations with tumor-specific IGF1R protein expression and BMI in a population-based cohort in Sweden, comprising 1,014 primary breast cancer patients without pretreatment enrolled 2002–2012 and followed for up to 13 years. This evidence concerns the gene IGF1R and breast carcinoma.